volume 29, issue 4, P524-531 2015
DOI: 10.3109/02688697.2015.1012051
View full text
|
Sign up to set email alerts
|
Share

Abstract: The intraoperative use of carmustine wafers in combination with Stupp regimen is a viable first-line treatment option of glioblastomas. The prognostic value of this treatment association should be evaluated in a multicenter trial, ideally in a randomized and placebo-controlled one.